RB1 and neoplasm: Using comprehensive genomic profiling, DeCoste et al. recently showed that MCPyV(+) cases had a lower tumor mutation burden than MCPyV(−) cases, with the latter carrying frequent mutations in TP53, RB1, and NOTCH family genes [10].